Genmab Launches Cash Tender Offer for Merus Common Shares at $97.00 per Share
ByAinvest
Tuesday, Oct 21, 2025 8:14 am ET1min read
GMAB--
MRUS--
Genmab is commencing a cash tender offer for all outstanding common shares of Merus N.V. at $97.00 per share. The offer is being made pursuant to a transaction agreement and is subject to certain conditions. Merus shareholders should read the tender offer documents before making a decision on whether to tender their shares. The offer will expire on December 11, 2025, or be extended if certain conditions are met.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet